ARUP Laboratories Urges FDA to Withdraw Proposed Rule Regulating Laboratory-Developed Tests
ARUP LaboratoriesARUP Laboratories today released the company's public comment on the FDA's proposed rule to regulate laboratory-developed tests (LDTs) as medical devices, urging the agency to withdraw the rule.